Ryan Watts
Founder bij DENALI THERAPEUTICS INC.
Vermogen: 49 M $ op 29-02-2024
Profiel
Dr. Ryan J. Watts is President, Chief Executive Officer & Director bij Denali Therapeutics, Inc. Hij zetelt in de Raad van Bestuur van Denali Therapeutics, Inc. Dr. Watts was voordien werkzaam als Director-Neuroscience Department bij Genentech, Inc. Hij behaalde zijn doctoraatsdiploma aan de Universiteit van Utah en een doctoraatsdiploma aan de Stanford Universiteit.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
DENALI THERAPEUTICS INC.
1.80% | 13-02-2024 | 2 480 671 ( 1.80% ) | 49 M $ | 29-02-2024 |
Actieve functies van Ryan Watts
Bedrijven | Functie | Begin |
---|---|---|
DENALI THERAPEUTICS INC. | Founder | 14-10-2013 |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Director/Board Member | 23-02-2023 |
Eerdere bekende functies van Ryan Watts
Bedrijven | Functie | Einde |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Founder | 01-02-2015 |
Opleiding van Ryan Watts
Stanford University | Doctorate Degree |
University of Utah | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DENALI THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Health Technology |